eli lilly new glp 1 is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating Eli Lilly's New $299 Month-Long
Description
*Real FuturHealth GLP1 users were compensated to provide their story

Fifteen to twenty minutes out of the refrigerator is sufficient
Semaglutide can also improve heart failure-related symptoms and inflammation in patients with obesity-related heart failure with preserved ejection fraction (HFpEP), and decrease the risk of major kidney disease events and cardiovascular-related mortality in patients with type 2 diabetes and chronic kidney disease(Butler et al 2024
The Amble Cares Program is built to close that gap

Chronic kidney disease also frequently coexists with T2D and HFpEF
